| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A decoy mutant ACE2 designed to reduce COVID-19
|
Maishan, Mazharul
|
|
|
43 |
9 |
p. 703-705
|
artikel
|
| 2 |
Advances in spatial mass spectrometry enable in-depth neuropharmacodynamics
|
Baijnath, Sooraj
|
|
|
43 |
9 |
p. 740-753
|
artikel
|
| 3 |
Advisory Board and Contents
|
|
|
|
43 |
9 |
p. i-ii
|
artikel
|
| 4 |
A novel anticancer pharmacological agent targeting mitochondrial complex I
|
Reyes-Castellanos, Gabriela
|
|
|
43 |
9 |
p. 706-708
|
artikel
|
| 5 |
Developing the Cannabinoid Receptor 2 (CB2) pharmacopoeia: past, present, and future
|
Whiting, Zak M.
|
|
|
43 |
9 |
p. 754-771
|
artikel
|
| 6 |
Emerging strategies for engineering Escherichia coli Nissle 1917-based therapeutics
|
Lynch, Jason P.
|
|
|
43 |
9 |
p. 772-786
|
artikel
|
| 7 |
Nanomedicine: controlling nanoparticle clearance for translational success
|
Zhu, Geyunjian Harry
|
|
|
43 |
9 |
p. 709-711
|
artikel
|
| 8 |
Subscription and Copyright Information
|
|
|
|
43 |
9 |
p. e1
|
artikel
|
| 9 |
Tackling chronic kidney disease in diabetic patients with finerenone
|
Das, Bhaskar
|
|
|
43 |
9 |
p. 799-800
|
artikel
|
| 10 |
The pharmacology of the TMEM16A channel: therapeutic opportunities
|
Al-Hosni, Rumaitha
|
|
|
43 |
9 |
p. 712-725
|
artikel
|
| 11 |
Toll-like receptor-mediated neuroinflammation: relevance for cognitive dysfunctions
|
Squillace, Silvia
|
|
|
43 |
9 |
p. 726-739
|
artikel
|
| 12 |
TRPC channels as emerging targets for seizure disorders
|
Yu, Ying
|
|
|
43 |
9 |
p. 787-798
|
artikel
|
Tijdschrift beschrijving